Measurement of the Interleukin Family Member ST2 in Patients With Acute Dyspnea. Results From the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) Study

Journal of the American College of Cardiology

Volumn 50, Issue 7, 2007, Pages 607-613

  Januzzi Jr , James L ^a   Peacock, W Frank ^b   Maisel, Alan S ^c   Chae, Claudia U ^a   Jesse, Robert L ^e   Baggish, Aaron L ^a   O'Donoghue, Michelle ^a   Sakhuja, Rahul ^a   Chen, Annabel A ^a   van Kimmenade, Roland R J ^f   Lewandrowski, Kent B ^a   Lloyd Jones, Donald M ^g   Wu, Alan H B ^d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^g NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; INTERLEUKIN 1 RECEPTOR; PROTEIN; ST2 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DYSPNEA; FEMALE; HEART FAILURE; HUMAN; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RISK ASSESSMENT; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; DYSPNEA; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECEPTORS, CELL SURFACE; SURVIVAL RATE;

EID: 34547582106     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.05.014     Document Type: Article

References (27)

1. Kieser A., Goodnight J., Kolch W., Mischak H., and Mushinski J.F. Identification of the primary growth response gene, ST2/T1, as a gene whose expression is differentially regulated by different protein kinase C isozymes. FEBS Lett 372 (1995) 189-193
2. Kumar S., Minnich M.D., and Young P.R. ST2/T1 protein functionally binds to two secreted proteins from Balb/c 3T3 and human umbilical vein endothelial cells but does not bind interleukin 1. J Biol Chem 270 (1995) 27905-27913
3. Yanagisawa K., Tsukamoto T., Takagi T., and Tominaga S. Murine ST2 gene is a member of the primary response gene family induced by growth factors. FEBS Lett 302 (1992) 51-53
4. Weinberg E.O., Shimpo M., De Keulenaer G.W., et al. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 106 (2002) 2961-2966
5. Sanada S., Hakuno D., Higgins L.J., Schreiter E.R., McKenzie A.N., and Lee R.T. IL-33/ST2 is a Critical Cardioprotective Fibroblast-cardiomyocyte Signaling System Activated by Mechanical Overload (2006) Paper presented at: American Heart Association Scientific Sessions; November 12-15, Chicago, IL.
6. Schmitz J., Owyang A., Oldham E., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23 (2005) 479-490
7. Weinberg E.O., Shimpo M., Hurwitz S., Tominaga S., Rouleau J.L., and Lee R.T. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation 107 (2003) 721-726
8. Shimpo M., Morrow D.A., Weinberg E.O., et al. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation 109 (2004) 2186-2190
9. Januzzi Jr. J.L., Camargo C.A., Anwaruddin S., et al. The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95 (2005) 948-954
10. Januzzi Jr. J.L., Sakhuja R., O'Donoghue M., et al. Utility of amino-terminal pro-brain natriuretic Peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department. Arch Intern Med 166 (2006) 315-320
11. Kuroiwa K., Li H., Tago K., et al. Construction of ELISA system to quantify human ST2 protein in sera of patients. Hybridoma 19 (2000) 151-159
12. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
13. Brint E.K., Xu D., Liu H., et al. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol 5 (2004) 373-379
14. Bruneau B.G., and de Bold A.J. Selective changes in natriuretic peptide and early response gene expression in isolated rat atria following stimulation by stretch or endothelin-1. Cardiovasc Res 28 (1994) 1519-1525
15. Ellmers L.J., Knowles J.W., Kim H.S., Smithies O., Maeda N., and Cameron V.A. Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosis. Am J Physiol Heart Circ Physiol 283 (2002) H707-H714
16. Baekkevold E.S., Roussigne M., Yamanaka T., et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol 163 (2003) 69-79
17. Carriere V., Roussel L., Ortega N., et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A 104 (2007) 282-287
18. Januzzi J.L., Morss A., Tung R., et al. Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort study. Crit Care 10 (2006) R37
19. Brunner M., Krenn C., Roth G., et al. Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intensive Care Med 30 (2004) 1468-1473
20. Oshikawa K., Yanagisawa K., Ohno S., Tominaga S., and Sugiyama Y. Expression of ST2 in helper T lymphocytes of malignant pleural effusions. Am J Respir Crit Care Med 165 (2002) 1005-1009
21. Oshikawa K., Kuroiwa K., Tago K., et al. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med 164 (2001) 277-281
22. Oshikawa K., Kuroiwa K., Tokunaga T., et al. Acute eosinophilic pneumonia with increased soluble ST2 in serum and bronchoalveolar lavage fluid. Respir Med 95 (2001) 532-533
23. Oshikawa K., Yanagisawa K., Tominaga S., and Sugiyama Y. Expression and function of the ST2 gene in a murine model of allergic airway inflammation. Clin Exp Allergy 32 (2002) 1520-1526
24. Oshikawa K., Yanagisawa K., Tominaga S., and Sugiyama Y. ST2 protein induced by inflammatory stimuli can modulate acute lung inflammation. Biochem Biophys Res Commun 299 (2002) 18-24
25. Tajima S., Oshikawa K., Tominaga S., and Sugiyama Y. The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis. Chest 124 (2003) 1206-1214
26. Sabatine M.S., Morrow D.A., de Lemos J.A., et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105 (2002) 1760-1763
27. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167